Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Simulating the diabetic environment modifies in vitro prostacyclin synthesis.

J Y Jeremy, D P Mikhailidis, P Dandona

    Diabetes
    |March 1, 1983
    PubMed
    Summary

    Altered metabolic factors in diabetes differentially impact vascular prostacyclin (PGI2) synthesis. Understanding these effects, like fatty acids and glucose, clarifies inconsistent PGI2 secretion data in diabetes research.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Endocrine Disorders and Peripheral Arterial Disease - A Series of Reviews Cushing Syndrome-Cortisol Excess.

    Current vascular pharmacology·2023
    Same author

    Growth Hormone, Atherosclerosis and Peripheral Arterial Disease: Exploring the Spectrum from Acromegaly to Growth Hormone Deficiency.

    Current vascular pharmacology·2023
    Same author

    Nonalcoholic Fatty Pancreas Disease: Role in Metabolic Syndrome, "Prediabetes," Diabetes and Atherosclerosis.

    Digestive diseases and sciences·2021
    Same author

    Multifocal arterial disease: clinical implications and management.

    Current opinion in cardiology·2020
    Same author

    Preface.

    Current vascular pharmacology·2018
    Same author

    Daylight saving time and myocardial infarction: should we be worried? A review of the evidence.

    European review for medical and pharmacological sciences·2018

    Area of Science:

    • Biochemistry
    • Endocrinology
    • Vascular Biology

    Background:

    • Contradictory data exist regarding prostacyclin (PGI2) secretion in diabetes.
    • Uncontrolled diabetes presents multiple metabolic abnormalities that may influence vascular PGI2 synthesis.

    Purpose of the Study:

    • To investigate the impact of key diabetic metabolic abnormalities on vascular PGI2 synthesis.
    • To elucidate the mechanisms behind variable PGI2 secretion observations in diabetes.

    Main Methods:

    • Utilized rat aortic rings in vitro to assess PGI2 synthesis.
    • Examined the effects of varying concentrations of fatty acids, glucose, insulin, pH, and ketone bodies.

    Main Results:

    • Increased fatty acids inhibited PGI2 synthesis in a dose-dependent manner, with linoleic and linolenic acids being most potent.

    Related Experiment Videos

  • Glucose showed a biphasic effect, stimulating PGI2 synthesis at moderate concentrations (10-30 mmol/L) but inhibiting at higher levels.
  • Insulin alone was inhibitory, but significantly stimulated PGI2 synthesis when combined with glucose under specific preincubation conditions.
  • Acidic pH (≤7.0) inhibited PGI2 synthesis, while ketone bodies had no significant effect.

    • Conclusions:

    • Metabolic alterations in uncontrolled diabetes exert differential effects on vascular PGI2 synthesis.
    • These findings help reconcile conflicting PGI2 secretion data in diabetes research.
    • Recommends detailed characterization of metabolic status in future diabetes-related PGI2 studies.